ASML vs BILL

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

BILL Holdings has a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score for definitive distress risk assessment. Despite solid revenue growth of 10.4% and strong gross margins of 83.85%, profitability remains fragile with negative operating and return metrics. The stock trades below analyst target of $61.59, suggesting upside potential, but weak recent price performance and insider selling raise caution. While valuation multiples are reasonable relative to sector averages, inconsistent earnings and lack of cash flow data limit confidence in a strong recovery.